EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma

Albatool AlKhazal, Samiha Chohan, Destani J Ross, Jinhwan Kim, Erin G Brown

Frontiers in Oncology · 04.03.2025 · 15

DOI: 10.3389/fonc.2025.1553511 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 04.03.2025. Verfasst von Albatool AlKhazal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, University of California, Davis, Davis, CA, United States. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Hartwell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma is a pediatric cancer that originates from neural crest cells and is the most common extracranial solid tumor in children under five years of age. While low-risk neuroblastoma often regresses spontaneously, high-risk neuroblastoma poses a significant clinical challenge. Recent advances in understanding neuroblastoma’s molecular mechanisms have led to the development of targeted therapies that aim to selectively inhibit specific pathways involved in tumor growth and progression, improving patient outcomes while minimizing side effects. This review provides a comprehensive review of neuroblastoma biology and emerging therapeutic strategies. Key topics include (a) immunotherapies and immunotargets, (b) non-coding RNAs (long non-coding RNA, microRNA, and circular RNA), (c) molecular biomarkers and pathways, and (d) limitations and future directions.

Schlagwörter

Stichwörter der Autor:innen

clinical and preclinical researchhigh-risk neuroblastomaneuroblastoma biologypediatric cancertargeted therapy

Autor:innen und Institutionen

  • Department of Surgery, School of Medicine, University of California, Davis, Davis, CA, United States.
  • Department of Biological Sciences, California State University, Sacramento, Sacramento, CA, United States.
  • Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Hartwell Foundation

Zitieren

APA

AlKhazal, A., Chohan, S., Ross, D. J., Kim, J., & Brown, E. G. (2025). Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1553511

Vancouver

AlKhazal A, Chohan S, Ross DJ, Kim J, Brown EG. Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1553511

BibTeX
@article{AlKhazal2025,
  author = {AlKhazal, Albatool and Chohan, Samiha and Ross, Destani J and Kim, Jinhwan and Brown, Erin G},
  title = {Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1553511}
}
Kostenlos starten →